NCT05325593 Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05308654 A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05303792 Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05298683 A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor Status NOT_YET_RECRUITING Phase PHASE2
NCT05293509 Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders Status WITHDRAWN Phase PHASE2
NCT05293210 Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2 Status UNKNOWN Phase PHASE3
NCT05292664 Venetoclax Basket Trial for High Risk Hematologic Malignancies Status RECRUITING Phase PHASE1
NCT05289908 Intrathecal Pemetrexed for Leptomeningeal Metastasis Status COMPLETED Phase PHASE1/PHASE2
NCT05289492 Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT05288062 Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma Status TERMINATED Phase PHASE2
NCT05286814 PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma Status RECRUITING Phase PHASE2
NCT05285813 A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure Status TERMINATED Phase PHASE2
NCT05284409 Comparative Study Between the Prophylactic Intravenous Administrations of Acetaminophen vs Dexamethasone vs Pethidine Regarding the Incidence of Shivering Induced by Single Shot Spinal Anesthesia in the Orthopedic Surgeries of the Lower Limbs Status COMPLETED Phase PHASE4
NCT05280275 A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible Status RECRUITING Phase PHASE1/PHASE2
NCT05279391 Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19 Status UNKNOWN Phase NA
NCT05272826 Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients Status RECRUITING Phase PHASE2
NCT05259839 A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05257083 A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3